← FDA Drug Approvals (Drugs@FDA)

BLUJEPA

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2025-03-25

Drug application

FDA Application #

NDA218230

Application type

New Drug Application

Brand name

BLUJEPA

Generic name

GEPOTIDACIN

Active ingredients

GEPOTIDACIN MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

Manufacturer

GlaxoSmithKline LLC

First approval

2025-03-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown